XML 50 R27.htm IDEA: XBRL DOCUMENT v3.20.1
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 28, 2020
Share-based Payment Arrangement [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity was as follows:

   Shares   Weighted Average Grant Fair Value 
Balance, December 28, 2019   1,863,124   $1.60 
Granted   533,000    0.41 
Forfeited   (18,500)   1.94 
Vested        
Balance, March 28, 2020   2,377,624   $1.33 

SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS

 

   For the three months ended March 28, 2020 
Performance price target  $5.25   $6.00   $7.00 
Expected volatility   48.3%   48.3%   48.3%
Interest rate   1.97%   1.97%   1.97%
Expected life (years)   3    3    3 
Dividend yield   %   %   %
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 28, 2020 and March 30, 2019 (no tax benefits were recognized):

 

   Three Months Ended   Three Months Ended 
   March 28, 2020   March 30, 2019 
Cost of product revenues  $13,977   $32,108 
Research and development   55,132    104,730 
Selling, general and administrative   89,356    679,004 
Total  $158,465   $815,842